Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and safety of agomelatine in children and adolescents with depressive or anxiety disorders
2012-003404-12Phase 2Completed
- Sponsor
- Servier
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of agomelatine in major depressive disorder (MDD), anxiety disorder, sponsored by Servier. Started Jan 2013; status: completed.
02
Drugs
agomelatine
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on 2012-003404-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003404-12.